Blood Borne Viruses, Protection against Infection with
Transcription
Blood Borne Viruses, Protection against Infection with
Protection against Blood Borne Virus Infections and Management of Sharps and Contamination Incidents Reference Number: 614 Author & Title: Dr Colin Payton, Consultant Occupational Physician Stephen Roberts, Occupational Health Manager Responsible Directorate: Human Resources Review Date: January 2015 Ratified by (committee): Health and Safety Committee Date Ratified: January 2012 Version: 4 Related Policies • • • • • • • Incident reporting and Management policy and procedure; including the management of Serious Untoward Incidents Waste Policy Linen Policy Decontamination Policy Sharps Injury Action Pack Universal Infection Control Policy Isolation Policy Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 1 of 48 Contents 1. Introduction ........................................................................................................................ 4 2. Purpose of this Policy ..................................................................................................... 5 3. Aims and Objectives of this policy .............................................................................. 5 4. Definitions .......................................................................................................................... 5 5. Blood borne viruses ........................................................................................................ 6 5.1 Human immunodeficiency virus (HIV) _________________________________ 6 5.2 Hepatitis B virus (HBV) _____________________________________________ 6 5.3 Hepatitis C virus (HCV) _____________________________________________ 7 5.4 Hepatitis D virus (HDV) _____________________________________________ 7 5.5 Viral Haemorrhagic Fevers __________________________________________ 7 6. Risks of Transmissions of BBVS ................................................................................. 8 6.1 Risk of infection ___________________________________________________ 8 6.2 Known infected patients ____________________________________________ 8 6.3 Use of Protective Clothing___________________________________________ 9 6.4 Disposal __________________________________________________________ 9 7. Pathology Specimens and venepuncture .................................................................. 9 7.1 All specimens _____________________________________________________ 9 7.2 Specimens from infected patients ____________________________________ 9 7.3 Venepuncture ____________________________________________________ 10 7.4 Arterial sampling__________________________________________________ 11 7.5 Venesection ______________________________________________________ 11 8. Testing Deceased Patients for Blood Borne Infections ....................................... 11 8.1 Procedures Following the Death of the Patient ________________________ 11 8.2 All patients with uncontrollable leakage of blood or body fluids __________ 11 8.3 Patients infected with a blood-borne infection or Hazard Group 3 infections12 9. Sharps Injury and Contamination Incident Action Pack...................................... 12 10. Exposure Prone Procedures ....................................................................................... 12 10.1 Exposure prone procedures ____________________________________ 12 10.2 Examples of procedures that are not exposure prone include: _______ 13 11. Responsibilities .............................................................................................................. 14 11.1 Role of Director of Infection Prevention and Control________________ 14 Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 2 of 48 11.2 Role of the Head of Health & Safety ______________________________ 14 11.3 The Manager _________________________________________________ 14 11.4 Members of Staff______________________________________________ 15 11.5 Occupational Health Department ________________________________ 15 11.6 Role of Infection control _______________________________________ 16 11.7 Role of Trade unions __________________________________________ 16 12. Training ............................................................................................................................. 16 13. Monitoring compliance ................................................................................................. 17 14. References........................................................................................................................ 18 Appendix 1: Consultant Checklist ................................................................................... 20 Appendix 2: Sharps and Contamination Incident Action Pack ............................... 21 Appendix 3 Patient Consent ............................................................................................ 33 Appendix 4: Information collected by occupational health...................................... 35 Appendix 5: Reducing the risk of sharps and contamination injury ..................... 38 Appendix 6: Protocol for healthcare works exposure to HIV................................... 41 Appendix 7: Root Cause Analysis Following Blood or Body Fluid Exposure .... 42 Appendix 8: Risk categories for Viral Haemorrhagic Fevers ................................... 45 Appendix 9: Rural African** Risk Assessment – Triage Form................................. 46 Equality Impact Assessment Tool ....................................................................................... 47 Ratification Checklist .............................................................................................................. 48 Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 3 of 48 1. Introduction Infections can be transmitted by inoculation of blood and other body fluids from infected patients. In the Health Service, precautions must be taken to protect staff and patients from this risk, while ensuring that infected patients receive the treatment and care they need. For this reason the Trust has adopted the policy of taking 'universal precautions' with blood and body fluids. The key to preventing transmission of blood-borne viruses (BBVs) is the strict observance of infection control measures which treat all blood, body fluids and body tissues from all patients as potentially infectious at all times. The BBVs which present most cross-infection hazard to health care workers (HCWs) are those associated with a carrier state with persistent replication of the virus in the human host and persistent viraemia. These include HIV and several hepatitis viruses, considered separately in the following paragraphs. Viral Haemorrhagic Fevers will also be considered briefly. For other rarer potentially blood-borne viruses, specialist microbiological/ virological advice should be sought. Any health care worker who is known to be carrying a blood borne virus or who suspects they may be a carrier MUST NOT undertake exposure prone procedures except under certain circumstances in the case of Hepatitis B carriers (DH, 2007). These individuals must be referred to Occupational Health for an assessment of their fitness to work, counselling and testing. For all patients and staff with blood-borne infections the normal rules of medical confidentiality apply. Personal health data relating to him/her must not be disclosed without their agreement to anyone for any purposes other than the health care of that patient. Adequate safeguards to protect against unauthorised disclosure must be adopted. Only in exceptional circumstances can confidentiality be breached e.g. infected healthcare worker continuing to undertake exposure prone procedures or seizure of medical records by court order. Consequently, patients should also be advised that confidentiality is not absolute and that doctors may be legally bound to disclose HIV status information. Should a patient be exposed to blood from an infected health care worker, the incident should be managed without revealing which member of the clinical team is infected. When a known infected patient is admitted to a ward, the clinician looking after the patient should only inform those nursing and medical colleagues who need to know in order to provide the necessary counselling, support and clinical care. Other staff do not need to know a patient has a BBV. All staff should be protecting themselves against BBV by adhering to safe working practices and the infection control policy. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 4 of 48 2. Purpose of this Policy This policy is primarily to guide against the transmission of Blood-borne Viruses from patient to health care worker however, it is equally applicable to patients where exposure to them from a health care worker’s body fluids occurs. 3. Aims and Objectives of this policy The policy aims to make explicit the principles of infection prevention and control which will minimise exposure to and the transmission of micro-organisms. 4. Definitions Percutaneous exposure Needle or other sharp object contaminated with blood or body fluids causing injury, a bite causing visible bleeding, or other visible skin puncture Contamination via mucous membrane Blood or body fluid splashes to the eyes, nose, or mouth Contamination via broken skin Blood or body fluids entering cuts, abrasions, or patches of eczema Source patient The person from whom the blood or body fluid originates Injured recipient The person exposed to blood or body fluids that have the potential to be infected with a blood borne virus Standard Principles of Infection Control All blood and body fluids are potentially infectious. Precautions are necessary to prevent exposure to them. These routine procedures are called Standard Principles of Infection Control (or Universal Precautions). The trust policy on infection control provides guidance on precautions that should be applied by all healthcare workers. Each member of staff is accountable for his/her actions and must follow safe practices. Standard Principles of Infection Control include: • Hand Hygiene and Skin Care • Protective Clothing Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 5 of 48 • Safe Handling of Sharps (including Sharps Injury Management). 5. Blood borne viruses 5.1 Human immunodeficiency virus (HIV) HIV has been isolated from blood, semen, vaginal secretions, saliva, tears, urine, breast milk, and cerebrospinal, synovial and amniotic fluids. However, only blood, blood products, semen, vaginal secretions, donor organs and tissues and breast milk have been implicated in the transmission of infection. There is no evidence that HIV is spread by close social contact even when this is prolonged, as in a family setting. Although HIV transmission may occur in health care settings, most HIV transmission occurs: • By unprotected penetrative sexual intercourse with an infected person (between men or between man and woman); • By inoculation of infected blood. At present in the UK this results mainly from drug users sharing blood contaminated injecting equipment; • From an infected mother to her baby before or during birth or through breast feeding. There is at present no vaccine to prevent HIV infection. 5.2 Hepatitis B virus (HBV) Hepatitis B virus surface antigen (HBsAg) may be found in blood and virtually all body fluids of patients with acute hepatitis B and carriers of the virus but blood, semen and vaginal fluids are mainly implicated in the spread of HBV infection. Transmission usually occurs: • By unprotected sexual intercourse; • By injecting drug users sharing blood contaminated injecting equipment; • Perinatally from an infected mother to her baby. Up to 90% of babies infected perinatally and around 5% of those infected as adults develop chronic carrier status. The persistence of the `e' antigen correlates with a high level of viral replication and increased infectivity. However some e antigen-negative carriers are also of high infectivity, and such carriers have been implicated in a number of transmission events in the healthcare setting. All HB surface antigen positive patients should be regarded as infectious. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 6 of 48 Immunisation, against HBV, provides protection in 90% or more of recipients. The Department of Health strongly recommends that all HCWs that are likely to be exposed to bodily fluids are vaccinated against HBV. Immunisation is not a substitute for good infection control practice since it provides no protection against infection with other BBVs. 5.3 Hepatitis C virus (HCV) HCV is the main cause of what was previously known as parenterally transmitted non-A non-B hepatitis. HCV is most frequently acquired by direct blood-to-blood contact and the commonest mode of transmission in the UK is the sharing of blood contaminated injecting equipment by injecting drug users. Both sexual and perinatal transmission can occur but in general these are less efficient modes of transmission. There is at present no vaccine to prevent HCV infection. 5.4 Hepatitis D virus (HDV) HDV causes infection only in those who have active HBV infection. HDV infection can occur either as co-infection with HBV or as super infection of an HBV carrier. Since HDV depends on an HBV-infected host for replication, prevention of HBV infection by immunisation will also prevent HDV infection. 5.5 Viral Haemorrhagic Fevers Viral haemorrhagic fevers (VHF) are potentially life-threatening diseases caused by a range of viruses. Most are endemic in a number of parts of the world, most notably Africa, parts of South America and some rural parts of the Middle East and Eastern Europe. The illness may lead to bleeding disorders increasing the opportunity for exposure to infected fluids. Accidental inoculation may result from needle stick or contamination of broken skin or mucous membranes by infected blood or body fluids. Four agents of VHF are of concern in the UK because of possible person-toperson spread. These are Lassa, Ebola, Marburg and Crimean/Congo haemorrhagic fevers. Any patient suspected of having a VHF must be kept in STRICT isolation and the Consultant Microbiologist and ICT contacted IMMEDIATELY The wearing of protective clothing is essential It is difficult to make a firm diagnosis solely on clinical grounds, so epidemiological evidence is essential in assessing a feverish patient with Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 7 of 48 a history suggestive of VHF. Clinicians should seek the help and advice of a specialist in infectious diseases or tropical medicine. The HPA website is also useful: http://www.hpa.org.uk/infections/topics_az/VHF/default.htm Experience has shown that most ill patients suspected of VHF will be suffering from malaria. Laboratory tests to exclude or confirm malaria should be undertaken as soon as possible. The laboratory must be notified in advance of the suspicion of VHF. Several blood films should be examined to exclude this diagnosis as false negative results occasionally occur. Treatment may need to be considered in the absence of a firm diagnosis. No laboratory work should be carried out on specimens from these patients (other than unavoidable emergency tests) until a blood film has been examined for the presence of malarial parasites. The blood sample should be taken by someone experienced in phlebotomy and should be hand delivered to the haematology biomedical scientist who must be made fully aware of the infection risks involved. 6. Risks of Transmissions of BBVS 6.1 Risk of infection The risk of transmission of BBVs is greater from patient to HCW than from HCW to patient. The risk to the HCW for each virus is proportional to the prevalence of that infection in the population served, the infectious status of the individual source patient, which may or may not be known, and the risk of a significant occupational exposure occurring during the procedures undertaken. In the health care setting transmission most commonly occurs after percutaneous exposure to a patient's blood by sharps injury. The risk of transmission to a susceptible HCW from an infected patient following such an injury has been shown to be around: 1. 1 in 3 when a source patient is infected with HBV and is `e' antigen positive 2. 1 in 30 when the patient is infected with HCV 3. 1 in 300 when the patient is infected with HIV. 6.2 Known infected patients Patients with simple chronic or acute hepatitis B, C or HIV infection do not require routine isolation. Patients with suspected or confirmed VHF must be isolated, ideally in specialist facilities (See Isolation Policy). All body fluids/tissues including breast milk should be handled with the same precautions as blood. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 8 of 48 6.3 Use of Protective Clothing Appropriate protective clothing must be available for use at all times and must be worn whenever there is a risk of contamination with blood or body fluids. Removal of all protective clothing must be followed by hand washing (See Universal Infection Control Precautions Policy). Allergy to latex is well recognized but uncommon. Staff should be wearing nitrile gloves when taking blood. Advice should be sought from Occupational Health if problems arise. 6.4 Disposal See Disposal of Waste Policy and Infection Control Precautions Policy for disposal of: Sharps, Contaminated Waste and Linen and Managing spillages of blood and body fluids. 7. Pathology Specimens and venepuncture 7.1 All specimens All specimens must be safely contained in a leak proof container and this must be enclosed in a sealed polythene bag. The request form should be placed in the side pocket if it is not attached to the bag. Care must also be taken to ensure that the outside of the container and bag remain free from contamination with blood. Needles must never be sent attached to syringes or alone in a plastic bag. 7.2 Specimens from infected patients These specimens should be packaged as trust procedure but the request form and specimen should be labelled "inoculation risk". The polythene bag should also be labelled. These specimens must not be sent via the vacuum tube system. If there is risk of spillage of contents then the polythene bag should be placed inside another i.e. “double bagging”. For individual patients/specimens advice may be sought from Infection Control. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 9 of 48 7.3 Venepuncture 7.3.1 Venous Blood sampling Only staff trained in the technique of venepuncture may undertake this procedure. 7.3.2 Vacutainer Procedure Nitrile gloves are recommended for use when taking blood and this skill should be developed and taught to all new practitioners. Factors which increase the risk of exposure to BBVs include: • • • • • The The The The The patient is difficult to "bleed" carer has a cut or broken skin etc. venepuncturist is inexperienced patient is restless patient is known to be infected with blood-borne viruses. Good practice includes: • • • • • Always use Vacutainer as the routine blood collecting system. Both 21g (green) and 22g (black) needles are available, plus a luer adapter for use with butterflies or venflons. Always take extra care to ensure bleeding has stopped after using the Vacutainer system. Never force blood from a traditional syringe and needle, through the Vacutainer tube seal, as this can result in the production of aerosols of blood and in the separation of the syringe from the needle. Never re-sheath a needle. Most needle stick injuries occur during re-sheathing. Never remove the tops off Vacutainer tubes. This is considered poor practice and may result in blood leaking out and causing a major contamination incident. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 10 of 48 7.4 Arterial sampling Due to the possibility of gross contamination this procedure should only be performed by junior medical staff that have been taught by an experienced senior. Pressure must be applied to the puncture site for at least 5 minutes, until bleeding stops. The needle MUST be replaced before transportation to the laboratory or blood gas analyser. 7.5 Venesection Following venesection the bag containing the unit of blood should be discarded into an approved sharps container. 8. Testing Deceased Patients for Blood Borne Infections It is the policy of the Trust that patients' blood should not be tested for HIV or Hepatitis viruses without their consent solely for hospital control of infection purposes. This is in keeping with national recommendations. It is the responsibility of the clinician to see that the patient's consent is obtained before the test is performed. 8.1 Procedures Following the Death of the Patient Also see Universal Infection Control Precautions Policy 8.2 All patients with uncontrollable leakage of blood or body fluids Every effort must be taken to prevent leakage by appropriate measures such as: • Seal wounds and cannulation sites etc. with a waterproof dressing • Spigot drains, catheters, other tubes etc. • Plug orifices where necessary using cotton wool swabs The body MUST be placed in a cadaver bag. See also Handling of Deceased Persons Policy. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 11 of 48 8.3 Patients infected with a blood-borne infection or Hazard Group 3 infections The body MUST be placed in a cadaver bag and a yellow 'Danger of Infection' sticker attached to the outside of the bag. The appropriate information must be secured on the OUTSIDE of the cadaver bag for mortuary staff protection. 9. Sharps Injury and Contamination Incident Action Pack The Sharps and Contamination Incident Action Pack (available via the intranet under Occupational Health) gives staff clear guidance on the procedure they should follow in the event of a sharps or contamination incident (see Appendix 2). These are classified as incidents where you are exposed to blood, serum or other body fluids. Incidents include: • • • • • Percutaneous injuries such as needle stick injuries or sharps injuries Bites (blood drawn Scratches (blood drawn) Contamination of the mucous membrane (through the mouth & nose) or conjunctivae (through the eye) Minor cuts, abrasions and other open skin lesions which become contaminated Managers in clinical departments should make all staff aware of the procedure. The document can be accessed on the intranet – Staff resources, Occupational Health 10. Exposure Prone Procedures 10.1 Exposure prone procedures Exposure prone procedures are those invasive procedures where there is a risk that injury to the worker may result in the exposure of the patient’s open tissues to the blood of the worker. These include procedures where the worker’s gloved hands may be in contact with sharp instruments, needle tips or sharp tissues (e.g. spicules of bone or teeth) inside a patient’s open body cavity, wound or confined anatomical space where the hands or fingertips may not be completely visible at all times. However, other situations, such as pre-hospital trauma care and care of patients where the risk of biting is regular and predictable, should be Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 12 of 48 avoided by health care workers restricted from performing exposure prone procedures. When there is any doubt about whether a procedure is exposure prone or not, advice should be sought in the first instance from a consultant occupational health physician who may in turn wish to consult the UK Advisory Panel for Health Care Workers Infected with Blood-borne Viruses (UKAP). Some examples of advice given by UKAP about exposure prone procedures are provided in Guidance on the management of HIV/AIDS infected health care workers and patient notification (issued under cover of Health Service Circular 1998/226). These may serve as a guide but cannot be seen as necessarily generally applicable as the working practices of individual health care workers vary. Procedures where the hands and fingertips of the worker are visible and outside the patient’s body at all times, and internal examinations or procedures that do not involve possible injury to the worker’s gloved hands from sharp instruments and/or tissues, are considered not to be exposure prone provided routine infection control procedures are adhered to at all times. 10.2 Examples of procedures that are not exposure prone include: • • • • • • Taking blood (venepuncture); Setting up and maintaining IV lines or central lines (provided any skin tunnelling procedure used for the latter is performed in a non-exposure prone manner i.e. without the operator’s fingers being at any time concealed in the patient’s tissues in the presence of a sharp instrument); Minor surface suturing; The incision of external abscesses; Routine vaginal or rectal examinations; Simple endoscopic procedures. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 13 of 48 11. Responsibilities 11.1 Role of Director of Infection Prevention and Control • • • • • • 11.2 Role of the Head of Health & Safety • • • • 11.3 Promote a safety first culture in the trust and challenge poor practice. To ensure there are safe systems of work in place to comply with the relevant aspects of the Hygiene Code to minimise the risk of health care associated Infections to staff, patients, and visitors. To ensure that the Trust has an approved documented process for managing the risks associated with inoculation incidents that is implemented and monitored. To ensure that sufficient resources are made available to replace conventional medical sharps with sharp-safe devices so far as is reasonably practical. To be advised on all matters relating to sharps and contamination incident, especially major incidents and kept fully informed of changes in health and safety legislation which might significantly affect safe working practices To receive annual reports on progress, performance and implementation of this policy. To support Divisions and Directorates in ensuring that appropriate action is taken as a result of a sharps incident To ensure any RIDDOR reportable incidents are reported to the Health and Safety Executive within the appropriate timeframe To liaise with the Complaints and Claims Manager when there has been an incident that has the potential to result in a claim To facilitate a formal investigation into high risk incidents and report findings to the Safer Staff Group each quarter. The Manager • • • • See Sharps Injury Pack for the management of workers following a sharps injury Follow the guidance in this document and maintain and promote a safe work place. Prevent exposure to sharps so far as is reasonably practical. For example: Where possible, replace the use of sharps with sharp safety devices or safer techniques Actively support the introduction of needle free systems and medical devices with sharps protection mechanisms Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 14 of 48 • • • • • 11.4 Members of Staff • • • • • • • • • • • • 11.5 Ensure all staff [including medical/nursing students, visitors, agency and bank staff] are trained to use sharps safely and dispose of them correctly Investigate all sharps incidents; allocating sufficient resources to prevent further incidences occurring and reviewing the effectiveness of measures taken. See Appendix - Root Cause Analysis Ensure all sharps incidents are communicated to the Health and Safety team within the required time frames Ensure the guidance in the Sharps Injury Pack [See Appendix] is followed. Timely testing of the source patient in these instances is vital to minimise any unnecessary anxiety in the healthcare work [HCW] and to reduce unnecessary use of antiretroviral drugs Provide feedback to staff on trends, serious incidents, results of investigations, learning opportunities and any necessary risk reduction activities required within your sphere of influence. See Sharps Injury Pack for the management of workers following a sharps injury Attend the appropriate training and refresher sessions Avoid passing sharps from hand to hand. Use a receiver so that the same sharp device is not touched by more than one person at the same time Employ a ‘no touch’ technique e.g. using forceps rather than fingers for steadying and separating tissues while stitching Avoid handling suture needles Try to stitch away from yourself Assemble devices with care and dispose of as a single unit [i.e. syringe and needle] Be especially vigilant during emergency procedures Ask for assistance when taking blood from or giving injections or infusion therapy to uncooperative patients Wear appropriate personal protective equipment [see universal infection control precautions policy] Dispose of the sharp immediately following its use. Never leave sharps lying around. Report all accidents, poor practice and near misses. Occupational Health Department • See Sharps Injury Pack for the management of workers following a sharps injury Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 15 of 48 • • 11.6 Provide a comprehensive hepatitis B vaccination programme for all healthcare workers exposed to blood and other body fluids at work at pre-employment and following a sharps or contamination incident Maintain an occupational health record of clinical care given to staff Role of Infection control Arrange annual site surveys of sharps bins to establish whether or not staff are adhering to Trust policy and disposing of sharps in a safe manner Inform senior management and department managers of the findings and recommendations to improve practice 11.7 Role of Trade unions Employers and workers' representatives shall work together at the appropriate level to eliminate and prevent risks, protect workers´ health and safety, and create a safe working environment, including consultation on the choice and use of safe equipment, identifying how best to carry out training, information and awareness-raising processes. 12. Training It is the responsibility of managers to ensure that all staff working in their area of responsibility have received suitable and adequate training and information about the infection control, safe handling and disposal of sharps. Staff should be supervised until they can demonstrate: • Safe method of working in line with the policy • The correct use of medical devices in current practice including those that incorporate sharps protection mechanisms where used • The correct disposal of sharps • Action to take in the event of an injury Infection control and sharps safety training incorporating the issues detailed above will be provided during the following sessions: • Occupation health Trust induction • Infection control Trust induction • Medical staff Induction and annual updates • Mandatory infection control annual update • All training sessions involving the use of sharps [i.e. venepuncture and cannulation] • Introduction of new equipment/systems that involve the use of sharps Staff training records can be located centrally via learning management system. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 16 of 48 13. Monitoring compliance Compliance with this policy is monitored by Safer Staff Group, as part of their regular review of inoculation and other medical sharps incidents data and trends analysis. Health and Safety, Occupational Health will collate sharps and contamination information for the Safer Staff Group. Information will include: location of incident; date and time; role of person injured, details about the incident and details of the number of incidents in each department per month. The Safer Staff Sub-group is a sub-group of the Health & Safety Committee. It is responsible for: • Reviewing inoculation and medical sharps incident data and trends analysis, against the required legal, regulatory and internal standards and identify areas of non-compliance. • Identifying required actions to achieve compliance and assess the implications of these actions for the Trust. • Identifying these actions to the accountable organisational lead and their Executive Director. Wherever possible this should be via the relevant sub-group member. • Identifying any significant risks and reporting these to the Health & Safety Committee. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 17 of 48 14. References Chief Medical Officers’ Expert Advisory Group on AIDS, London, Department of Health MMWR Supplement (1987) “Recommendations for Prevention of HIV transmission in health-care settings” Aug 21 vol 36: no 2 Department of Health guidance on HIV PEP. Http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/ digitalasset/dh_4083640.pdf Department of Health (2005) HIV Infected Health Care Workers: guidance on management and patient notification. http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/HIV/fs/en Department of Health (2006) Immunisation against Infectious Disease. Online Department of Health (2008) HIV Post-exposure prophylaxis. Guidance from the UK DOH AIDS/HIV Infected Health Care Workers: Guidance on the Management of Infected Health Care Workers and Patient Notification.. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGu idance/DH_4116415 Expert Advisory Group on AIDS (1998) Guidance for Clinical Health Care Workers – Protection against Infection with Blood-borne Viruses http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthser vicecirculars/DH_4003818 Health & Safety Executive Advisory Committee on Dangerous Pathogens (2008) Protection against blood borne infections in the workplace: HIV and Hepatitis. Hepatitis C Infected Health Care Workers HSC 2002/010 http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirc ulars/DH_4004561 Hepatitis B Infected Health Care Workers. HSC 2000/020. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirc ulars/DH_4004553 Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 18 of 48 HIV testing for patients attending general medical services NATIONAL GUIDELINES Clinical Effectiveness and Evaluation Unit Royal College of Physicians 2005 The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare Associated Infections. JHI; 47:S1-S82 Working Party of the British Orthopaedic Association (1991) Guidelines for the Prevention of Cross Infection between Patients and Staff in Operating Theatres with special Reference to HIV and the Blood-borne Hepatitis Viruses London: British Orthopaedic Association U.K Health Departments (1998). Health Service Circular (HSC 1998/266) AIDS/HIV Infected Health Care Workers: Guidance on the Management of Infected Health Care Workers and Patient Notification. Health & Safety Executive. [1995]. Reporting of Injuries, Diseases and Dangerous Occurrences Regulations [RIDDOR Explained, Version 6], Suffolk: Health and Safety Executive. Available at: http://www.hse.gov.uk/riddor/index.htm Healthcare Commission. [2008]. The annual health check 2008/09 Assessing and rating the NHS. London: Healthcare Commission. Available at: http://www.healthcarecommission.org.uk/publicationslibrary Department of Health. Hepatitis B, Chapter 18, The Green Book. London: Department of Health, November 2009 The management of health, safety and welfare issues for NHS staff. The Blue Book. 2005 Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 19 of 48 Appendix 1: Consultant Checklist Name and Title of Individual Date Consulted Sharon Bonson, Assistant Director of Nursing Head of Health and Safety Head of Risk and Assurance Senior Infection Control Nurse A Ibbotson Senior Occupational Health Nurse Kim Gupta, Consultant Lors Alford, RCN Representative 18.03.2011 18.03.2011 18.03.2011 18.03.2011 18.03.2011 18.03.2011 12.08.2011 16.06.2011 Name of Committee/Group Date of meeting Health & Safety Committee 31.01.12 Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 20 of 48 Appendix 2: Sharps and Contamination Incident Action Pack SHARPS INJURY AND CONTAMINATION INCIDENT ACTION PACK 1.0 Introduction ‘A combination of training, safer working practices and the use of medical devices incorporating sharps protection mechanisms can prevent more than 80 per cent of needlestick and sharps injuries’ [The Blue Book, 2005] It is the responsibility of managers to ensure that all staff working in their area of responsibility have received suitable and adequate training and information about the safe handling and disposal of sharps. Staff should be supervised until they can demonstrate: • Safe working practices following training • The correct use of medical devices in current practice including those that incorporate sharps protection mechanisms where used • The correct disposal of sharps • Action to take in the event of an injury All staff, patients and visitors involved in a sharps or contamination incident should follow this procedure. 2.0 Definitions A blood or body fluid exposure incident refers to an incident where there is: • • • • • • 3.0 Percutaneous injuries such as sharps injuries caused by medical devices Bites (blood drawn) Scratches (blood drawn) Contamination of the mucous membrane (through the mouth & nose) or conjunctivae (through the eye) Minor cuts, abrasions and other open skin lesions which become contaminated First aid The responsibility for compliance with these instructions lies with the injured employee and his / her immediate manager. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 21 of 48 3.1 Immediate action to be taken by the employee (Recipient) Puncture wound, cut, scratch or broken skin: • Encourage bleeding but the wound should not be sucked. • Run site of exposure / injury under warm water then wash the site liberally with soap and warm water but without scrubbing. • Cover with dressing/plaster, if the wound is larger and/or requires medical attention contact the Occupational Health Department, during opening hours or attend A+E. Exposed mucous membranes or conjunctivae • Should be irrigated with copious amounts of water. 4.0 4.1 Reporting procedure Notify department manager / person in charge immediately • • • An urgent risk assessment should be undertaken to establish the risk of exposure to blood borne virus (see Section 7 on Risk Assessment). If you have concerns about exposure to HIV please contact the switchboard who will put you though to the doctor on call for HIV post exposure prophylaxis. If a significant exposure has not occurred, e.g. a clean, uncontaminated sharps injury, no further action is required other than completing an incident form. The manager should make sure the patient (source) has been tested for HIV, Hepatitis B and C infection, subject to informed consent – see section 6. 4.2 Notify Occupational Health Report all sharps and contamination incidents to Occupational Health straight away by phoning the Sharps Information Line Tel: 1001, External calls: 01225 821001. If the nurse is not available you will hear the following message: “This is the Sharps Incident Information Line at the Royal United Hospital. Please listen to the following message: • • • • Follow the instructions in the Sharps and Contamination Action pack for first aid treatment and blood tests. Please leave a message on this answerphone. Speaking clearly, give your full name; date of birth; the place, date and time the incident occurred. Also leave your contact telephone number, mobile number and bleep. This answer phone will be checked each day Monday to Friday. You will be contacted as soon as possible. If you have serious concerns about blood borne infection and are unable to talk to an Occupational Health nurse please contact the Emergency Department and ask for an urgent assessment tor HIV post exposure prophylaxis (PEP). Lastly, the initial blood sample from the injured worker should be sent for ‘storage only’. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 22 of 48 The patient should have samples sent, only with informed consent, for Hepatitis B, C and HIV infection. If the Occupational Health Nurse is unable to contact the injured worker within 48 hours of the incident an email will be sent to the manager of the department (if known) where the injury occurred requesting them to contact the injured worker and refer them to Occupational Health. 5. 5.1 • • • • • Responsibilities following an inoculation injury Manager / Person in Charge Carry out a risk assessment of the incident immediately. See Section 7. If you think there may be a high risk of exposure to blood borne viruses including HIV phone Occupational Health during working hours or the the Emergency Department out of hours and ask for an urgent assessment tor HIV post exposure prophylaxis (PEP). If in doubt, do not delay - phone for advice. If the sharps incident involved a known patient ask them for their consent to test for HIV, Hepatitis B and C infection. The person taking blood from the patient should contact the laboratories and ask for the blood tests to be processed quickly if there is a high risk of the injured worker being exposed to HIV, Hepatitis C or B infection. See Section 6. Refer the injured worker to Occupational Health to have a blood sample taken for ‘storage’; their Hepatitis B immunity checked and counselling if required. Complete an incident form. Investigate the incident and take steps to prevent a further sharps incident. Send the incident form to the risk management department within the required time frame. 5.2 All Staff It is the responsibility of all health care workers to: • Adhere to safe working practices, health and safety training and trust policies concerning infection control and the use and disposal of clinical waste. • Undertake Infection Prevention and Control training programmes and updates which include Standard Precautions, Hand Hygiene, Disposal of Sharps, and Management of Inoculation Injuries. • Comply with the instructions in the Sharps Injury Action Pack. • Report all sharps and contamination incidents to their manager or team leader so a risk assessment can be carried out straight away. • Contact Occupational Health as soon as possible so that they can review your exposure to blood or bodily fluids and answer any concerns you may have. • Contact Occupational Health to arrange blood tests and to check blood test results. Blood tests normally take up to 5 working days to be processed unless the results are urgent. • Injured staff can arrange to have their blood tests and samples taken by another health professional but they must follow this protocol. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 23 of 48 5.3. • • • Occupational Health The Occupational Health Department will advise the manager on how to comply with this procedure when requested to do so. They will check the patient’s (source) results and advice the injured worker if they require blood tests to check for HIV, Hepatitis B and C infection. Occupational Health will not obtain blood samples from any hospital patient. If the source patient is unknown or refuses testing the Occupational Health Department will arrange for the employee to have the following tests: o At 6 weeks testing for Hepatitis C virus RNA o At 12 weeks testing for Hepatitis C virus RNA and antibody o At 24 weeks testing for Hepatitis B, Hepatitis C virus antibodies, HIV antibodies and a further storage sample. NB: The fact that the injured employee has been vaccinated against Hepatitis B does not preclude the need to take blood from the injured member of staff and the source patient and to follow this protocol. Virology Request Form for Injured Worker Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 24 of 48 Use a yellow topped bottle to collect a 5 ml sample of blood. Include the following details on the virology request form: • • • • • NHS Number Staff Surname Injured worker’s name Consultant Dr C Payton Clinical details section Sharps injury; Name and date of birth of the patient if known; Date and time of the sharp’s injury. Other virology investigations First storage sample Table: Post exposure prophylaxis HBV# Injured Worker - History Hepatitis B Vaccination One or less doses of Hepatitis B vaccine Consider the following treatment [Always check the latest edition of the Green Book] Commence an accelerated course of Hepatitis B vaccine. HBIG x 1 dose if the patient is Hepatitis B positive Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 25 of 48 Partially completed a course of Hepatitis B vaccine Completed a course of Hepatitis B vaccine but the Hepatitis B antibody levels are unknown Hepatitis B antibody levels are 11–99mIU/ml Hepatitis B antibody levels are less than 10mIU/ml (None responder to Hepatitis B vaccine) Complete the course following an accelerated schedule. Check Hepatitis B antibody levels in 8 weeks after the last vaccine Hepatitis B antibody test will be performed if the last hepatitis B vaccine was less than a year ago. Otherwise, a further Hepatitis B vaccine will be given and antibody levels checked 8 weeks after. Consider a booster dose Hepatitis B HBIG x 1 dose and a 2nd dose in 1 month Consider a booster dose Hepatitis B #: Always check the Department of Health Green Book for up to date guidance 5.4 Medical Team / GP If the source patient needs to be informed of a positive blood result then this will be done by the medical team caring for the patient. Appropriate referrals will be made by the medical team. If the patient has been discharged then the medical team will inform the patient’s GP. • • • • • 6. 5.5 Occupational Health Physician /Emergency Department Doctor Risk assess the incident and the need for immediate treatment including HIV PEP. Arrange and provide clinical support to those requiring HIV PEP. Review the source patient’s blood results if known and advise the worker accordingly. Ensure Occupational Health is notified of the incident so further blood tests and support can be provided if required. Consent to test the patient (source) for HIV, Hepatitis B and C virus 6.1 • • • Patient (source) blood test The injured worker must not be the person who takes the blood sample from the source patient. The blood test must be undertaken by a competent professional. The source patient must be given a pre-test discussion and asked to consent to testing for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and HIV using a clotted yellow topped bottle. The source patient should be provided with appropriate information about the implications of these tests and appropriate time to consider and discuss them (See Protection against Blood Borne Virus Infections and Management of Sharps and Contamination Incidents Policy, Appendix 2, Testing Information for Patients). Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 26 of 48 • • Inform the patient that their blood results will be seen by Occupational Health staff so they can determine if the injured worker requires further testing. Occupational Health will treat this information confidentially. If the source patient requires any further advice or information regarding the testing, assistance can be sought from the GUM clinic. Virology Request Form for the Patient Use a yellow topped bottle to collect a 5 ml sample of blood. Include the following details on the virology request form: • • • NHS Number Patient’s number o Surname Patient’s name o Consultant Patient’s consultant Clinical details section Sharps injury; Name of injured worker; Date and time of the sharp’s injury. Test for HIV, virus”. The consultant will be the patient’s consultant. Test Required Tick Hepatitis B and C Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 27 of 48 • Other virology investigations HIV test The results of the blood test should be filed in the patient’s health record. 6.2 Unconscious patient or patient lacking capacity to consent If the source patient is unconscious or lacks capacity to give consent, blood can only lawfully be tested for serious communicable diseases if it is reasonably held to be in their best interests in accordance with the Mental Capacity Act 2005. 6.3 Patient refuses consent If the source patient refuses consent or is unable to give informed consent, under no circumstances should testing will be carried out, even on previously stored blood. 6.4 Neonates and consent Where the source patient is a neonate, the risk assessment will need to be based on the mother’s risk factors for blood borne viruses. Antenatal screening results will support your risk assessment but further testing is recommended if there is a high risk of exposure to infection. The baby’s blood should not be tested. 6.5 Children under the age of 16 Children under the age of 16 should not be tested unless the parent/guardian gives consent. The consent of the treating paediatrician is required before the parent/guardian is approached. 6.6 Deceased patient If the source patient is deceased, the taking and testing of blood samples requires consent from a nominated representative or a close relative to the deceased. 7.0 Risk assessment Following all sharps and contamination injuries a risk assessment should be carried out by the department manager where the incident occurred. Managers may wish to delegate this task to a competent person. The risk assessment will determine the injured workers likely exposure to Hepatitis B, C or HIV infection and need for HIV PEP. 7.1 Risk factors Type of body fluid to which the recipient has been exposed – Blood carries the highest risk, but blood borne viruses can be transmitted by other body fluids, especially if they are contaminated by blood. High risk body fluids: • Amniotic fluid, vaginal secretions, semen, human breast milk, cerebrospinal fluid, peritoneal fluid, pleural fluid, pericardial fluid, synovial fluid, fluid from burns or skin lesions, saliva in association with dentistry, unfixed tissues and organs. • Low risk body fluids: • Urine, saliva, faeces, vomit, or tears (unless they are visibly blood stained). Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 28 of 48 Route of exposure – If the health care worker’s skin is intact it is impervious to the three viruses. If the skin is not intact then transmission may occur. Splashes of blood or body fluids onto mucous membranes may result in virus transmission, although the risk is considerably lower than for percutaneous exposure. Nature of exposure – Contaminated hollow-bore needles are more likely to transmit viruses than solid needles. Needles that have been present in a blood vessel are more likely to transmit viruses than needles used for intramuscular injection. Transmission is less likely to occur from a needle containing dried blood. Depth of injury – The risk of transmission increases depending on the depth of the injury, a deep injury is likely to be a higher risk than a puncture wound or a surface scratch. Personal Protective Equipment – If gloves were worn at the time of the incident there is a wiping effect as a needle pierces the glove, which may reduce the likelihood of transmission. Safety glasses, goggles, or a visor would offer the health care worker more protection in the event of a blood or body fluid splash to the eyes, nose, or mouth. The source patient – If the source patient is known to have blood borne virus (BBV) tests within the last year then their blood borne virus status may be ascertained from records. If the blood borne virus status of the source patient is unknown then a 5ml clotted blood sample should be taken for BBV test with informed consent. A risk assessment should also be carried out to determine if the injured worker has had a significant exposure to HIV, Hepatitis B and C infection. 7.2 • • • • High risk patients Known to have or be a carrier of a blood borne virus. A known close contact of a Hepatitis B, Hepatitis C, or HIV positive individual. Had unprotected sex with someone who has a blood borne virus. Sharing injecting equipment with someone who has a blood borne virus. The following factors are associated with increased risk of occupationally acquired Hepatitis C infection: • History of intravenous drug misuse and or multiple sexual partners • History of a blood transfusion in the UK before 1992 • Received a blood transfusion or injections abroad The following factors are associated with increased risk of occupationally acquired HIV infection: • Deep injury • Visible blood on the device which caused the injury • Injury with a needle which had been placed in the source patient's artery or vein Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 29 of 48 • 7.3 • • • • Terminal HIV-related illness in the source patient Medium risk patients Had multiple sexual partners Had unprotected sex abroad (may be at high risk if had unprotected sex in countries with high prevalence of HIV) Born outside the UK or the Republic of Ireland – people from certain parts of the world have a high risk of HIV If the incident arose from an unknown source, a risk assessment may still be possible in the light of local knowledge of the prevalence of blood borne virus infections. 7.4 Hepatitis B status of the health care worker Health workers should contact Occupational Health to check they are fully immune to the hepatitis B virus. A further hepatitis B vaccine may be advisable following a sharp’s injury. 8.0 Sharps incidents involving the public • • • • • Provide first aid and send the member of the public to the emergency department to be risk assessed for exposure to HIV, Hepatitis B and C infection. Complete an incident form. Document the date and time of injury, location and nature of injury. Consider the need for vaccination against Hepatitis B infection. If required obtain the injured person’s consent and commence an accelerated course of Hepatitis B vaccine (0, 1, 2 and 12 months). The first dose should be given immediately. Subsequent doses should be organised through the G.P. With the patient’s consent take a baseline 5 ml clotted blood sample and label “Sharps Injury to a Member of the Public”. The injured person’s blood form should state: NHS Number Injured person’s hospital number Surname Injured person’s name Consultant ED consultant Clinical details section Sharps injury to Member of the Public; Name and date of birth of the patient (source) if known; Date, time and location of the sharp’s injury. o Other virology investigations First Storage Sample o o o o • • Further counselling may be offered via the G.P or the Genito-Urinary Medicine Department. If the source of the sharp is known obtain blood from the source patient for testing for blood-borne viruses (consent required). High risk source patients should be discussed with the On Call Doctor for HIV PEP. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 30 of 48 • If the source of the injury is unknown, a blood test is refuses or the source patient is positive to the above infections arrange for the member of public to have the following tests via their GP: o At 6 weeks testing for Hepatitis C virus RNA o At 12 weeks testing for Hepatitis C virus RNA and antibody o At 24 weeks testing for Hepatitis B, Hepatitis C virus antibodies, HIV antibodies and a further storage sample. Please do not send any results to Occupational Health. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 31 of 48 FIRST AID SHARPS INJURY Encourage bleeding, squeeze the wound gently but do not suck Wash well with soap under running water but do not scrub Cover the wound using a clean, dry, waterproof dressing SPLASHED WITH BODY FLUID Eyes: Wash in plenty of running water (before and after removal of contact lenses if worn) Mouth: Spit, do not swallow, rinse many times with running water Skin: Wash in plenty of running water REPORTING AN INCIDENT DEPARTMENT MANAGER OR PERSON IN CHARGE INJURED WORKER REPORT THE INCIDENT IMMEDIATELY OCCUPATIONA L HEALTH Phone 1001 COMPLETE INCIDENT FORM High Risk Exposure to Blood Borne Viruses Including HIV? RISK ASSESSMENT OF INJURY PHONE SWITCHBOARD Occupational Health Physician or Doctor on call for HIV PEP IF THE PATIENT IS KNOWN AND GIVES INFORMED CONSENT - Blood Test for HIV, Hepatitis B and C Virus REVIEW RISK ASSESSMENT CHECK PATIENT'S BLOOD RESULTS REVIEW IMMUNITY TO HEPATITIS B RECOMMEND THE INJURED PERSON HAS A BLOOD SAMPLE TAKEN FOR STORAGE Report Incident to Occupational Health High Risk Exposure to Blood Borne Viruses Including HIV? Refer to Occupational Health Physician Counselling and advice for injured worker Sharps injury from unknown source, unconsenting patient or the patient has Hepatitis B, C or HIV infection. Blood tests: 6 weeks - Hepatitis C RNA 12 weeks - Hepatitis C RNA and antibodies 24 weeks - Hepatitis C and HIV, antibodies ,Hepatitis B virus and blood sample for storage Offer Vaccination or Immunoglobulin if Required Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 32 of 48 Appendix 3 Patient Consent Obtaining Consent for Testing Source Patients for Blood Borne Viruses and Patient Information Testing information for patients A member of staff has been accidentally exposed to your blood or body fluids during the course of their work. We are requesting to test your blood in order to assist the member of staff. There are three specific viruses that are covered in this information sheet. All three viruses can be present in your body without your knowledge. We ask patients in this situation if we can test them for: • HIV (Human Immunodeficiency Virus): A virus that can be transmitted through blood, body fluids, and sexual exposure. Examples include sharing needles, syringes or equipment for drugs, tattoos, body piercing, through unscreened blood transfusions, and from mother to baby. • Hepatitis B: A virus that affects the liver and is passed on in the same way as HIV. • Hepatitis C: A virus that affects the liver and is usually passed on through blood or sharing needles or other equipment during recreational drug injecting. Other examples include tattoos, body piercing, and unscreened blood transfusions. What does the test involve? A 5 ml sample of blood will be taken from your arm. If any of the results are positive, the test will be repeated to confirm the result. Who will know my test result? The result will be given to you in confidence and your own doctor will be informed. The doctor looking after the member of staff affected will be informed, unless you request otherwise. What if I am found to have one of these viruses? If the test shows that you have one of these viruses, you will be offered care, support, and treatment. What are the benefits of having these tests now? You can have these viruses with or without any symptoms. If you have Hepatitis B or Hepatitis C virus, treatment can often help to cure you and reduce the damage to your liver. New treatments are available for individuals with HIV. The treatment for HIV may be more effective if it is given before any serious illness develops. How can this help the member of staff who has been exposed to my blood? If you are carrying a blood borne virus the member of staff affected can be followed up to see if the virus has been transmitted to them and treated if necessary. Will having the HIV test affect my chances of getting life insurance? Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 33 of 48 Doctors do not need to report negative HIV tests when writing insurance reports. Insurance companies should no longer ask whether you have had an HIV test, they should only ask whether or not you are HIV positive (As agreed by the Association of British Insurers 1994). What are the drawbacks of having the HIV test? If you do have HIV, the benefits of knowing usually outweigh the disadvantages, which may include difficulties in relationships with family and friends or, for some, employment issues. Travel to some countries is currently restricted for people who know they have HIV. CONSENT If you have any further questions, please do not hesitate to ask a member of staff. When you have read this information sheet and asked any questions please sign below. You may have a copy of this information sheet. I fully understand the information given to me and have had the opportunity to ask questions regarding the tests. I agree/do not agree to have my blood tested for HIV, Hepatitis B, and Hepatitis C. Signed………………………………………………… Date……………………. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 34 of 48 Appendix 4: Information collected by occupational health 1. Details of Incident Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 35 of 48 2. Personal Information 3. Staff Details Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 36 of 48 4. Donor Details Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 37 of 48 Appendix 5: Reducing the risk of sharps and contamination injury Reducing the risk of sharp injuries / contamination incidents 1.0 Minimising the risk of exposure to blood borne viruses (BBVs) • • • • • • • • • • • • • 2.0 ALWAYS adhere to safe working practices; health and safety training and infection control procedures ALWAYS wash hands before and after contact with each patient, and before putting on and after removing gloves; ALWAYS change gloves between patients and between different procedures on the same patient; Cover existing wounds, skin lesions and all breaks in exposed skin with waterproof dressings. If hands are extensively affected seek advice from Occupational Health; ALWAYS wear gloves where contact with blood can be anticipated; Avoid sharps usage where possible. Where sharps usage is essential, exercise particular care in handling of all items; Dispose of sharps immediately at the point of use using a sharps bin. Do not carry sharps across a clinical area Sharps bins must be correctly assembled. Do not overfill sharps containers Avoid wearing open footwear in situations where blood may be spilt, or where sharp instruments or needles are handled. Healthcare workers must not wear open footwear in clinical situations; Clear up spillage of blood promptly and disinfect surfaces wearing appropriate protective clothing e.g. apron and gloves. If there is glass involved in the spillage use suitable equipment to clear it up and do not pick up glass fragments by hand. Wear gloves when cleaning equipment prior to sterilisation or disinfection, when handling chemical disinfectant and when cleaning up spillages. Wear eye protection in situations where splashes and aerosols may be generated Follow safe procedures for disposal of contaminated waste. Reducing sharp and contamination incidents in surgery Have no more than one person working in an open wound/body cavity at any time [unless essential to the safe outcome of an operation] • Use a ‘hands-free’ technique where the same sharp instrument is not touched by more than one person at the same time, prohibit hand to hand passing of sharp instruments during an operation • Assure safer passage of necessary sharp needles and instruments via a ‘neutral zone’ and announce when a sharp instrument is placed there. The ‘neutral zone’ may be a tray, kidney dish or an identified area in the operative field Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 38 of 48 • • • • • • • • • • • 3.0 Ensure that scalpels and sharp needles are not left exposed in the operative field, but always removed promptly by the scrub assistant having been deposited in the neutral zone by the operator or assistant Use instruments rather than fingers for retraction, and for holding tissues while suturing Let falling objects fall. Don’t try to catch falling instruments or glassware, and stand well clear of them. It’s better to clean up a mess or replace an instrument than to risk injury and infection Use appropriate instruments to handle needles and to remove scalpel blades Direct sharp needles and instruments away from own non-dominant, or assistant’s hand Remove sharp suture needles before tying suture; tie suture with instruments rather than fingers Avoid scalpel injuries associated with assembly/disassembly, by using scalpels which are either disposable, have retractable blades or which incorporate a blade release device Consider double gloving with a larger pair of gloves innermost for optimum comfort. Double gloving does not prevent sharps injury but has been shown to effect up to a six-fold decrease in inner glove puncture. In the event of percutaneous injury, the volume of blood transmitted may also be reduced due to the enhanced wiping effect of two layers of glove [HSC 1998]. Consider replacing the use of blades with laser surgery or electrocautery devices to be used as cutting devices Consider the use of blunt-tipped needles, stapling devices or skin glue as they are all safer alternatives to sharp suture needles Use a sharps disposal device [sharps pad] for checking/counting of all sutures and scalpel blades during surgery Patient-Administered Injections and Finger-Prick Tests If the patient is self-administering medication/testing they must dispose of the sharps themselves and therefore have a sharps bin available. If a healthcare professional has to administer insulin to a patient, this should ideally be given via a syringe. Further advice may be sought from the diabetes specialist nurses if an insulin pen has to be used. 4.0 • • • • • Sharps bin safety It is the responsibility of the person using the sharp to dispose of it safely Sharps should be placed directly into an approved sharps disposal container as soon as possible after use Always take a sharps disposal bin to the point of use Needles and syringes should be discarded as a single unit, where possible Where it is necessary to disassemble a needle and syringe, such as before transferring blood from a syringe to a pathological specimen bottle, the needle should be placed in the sharps container before transferring the blood Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 39 of 48 • • • Vacuum collection systems should be used according to the manufacturer’s instructions. The plastic barrels of such devices should not be reused Re-sheathing should be avoided, as should bending/breaking needles Staff who need to visit a patient in their own home as part of their care plan, must ensure that all sharps waste that is generated during the visit is correctly disposed of into a sharps bin. This bin must then be fully sealed and the label correctly filled in. The bin must then be placed in an upright position in the vehicle and then transported in the vehicle back to the Trust premises. The bin will be stored in a secure location within the staff member’s department at the Trust. The staff member must then call X4141 to arrange for a sharps waste collection. Sharps bins must always be: • Compliant with UN3291 and BS7320 standards • Correctly assembled and labelled • Available in a range of sizes to suit the devices being discarded. For example guide wires and introducers require a deep box. [seek advice from the infection control department] • Available at all locations where sharps are used • Secured to an appropriate bracket at approximately below shoulder height [so that no staff are having to reach up to dispose of a sharp] and out of the reach of children or carried in the appropriate sharps bin container tray [available from infection control department or your sharps bin supplier] • Attempts must not be made to retrieve items from a sharps container • Sharps bins should be locked closed when two-thirds to three-quarters full. Sharps must not be pressed or ‘shaken’ down in order to make more room • Locked and disposed of as clinical waste in accordance with The Management and Disposal of Waste policy [605/2008]. • Carried using the handle or in a container tray Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 40 of 48 Appendix 6: Protocol for healthcare works exposure to HIV Protocol for the Post Exposure Prophylaxis for Healthcare Workers Occupationally Exposed to HIV In the event of a member of staff sustaining a sharps injury resulting in exposure to material suspected to be infected with HIV contact the Consultant Occupational Physician during working hours or the Emergency Department out of hours for urgent advice. They will investigate the circumstances of the exposure and of the source patient and will advise on the use of POST EXPOSURE PROPHYLAXIS drugs. During working hours phone Occupational Health (4064). Out of hours contact The Emergency Department The POST EXPOSURE PROPHYLAXIS pack is held in the Emergency Department, in the pharmacy cupboard pyxis machine and is labelled “post exposure HIV pack”. It contains 3 days’ supply of: One Combivir tablet b.d. (300mg zidovudine + 150mg lamivudine) plus Two Kaletra tablets b.d. (Lopinavir200mg/Ritonavir50mg) Kaletra often causes diarrhoea so the pack also includes Loperamide to counteract this. If the Occupational or Emergency Physician advises the use of POST EXPOSURE PROPHYLAXIS the whole pack should be given to the member of staff who should take the first doses of each drug as soon as possible. In potentially high risk situations the first doses may be given pending further investigation of the incident. This protocol also covers staff of the following organisations: • Avon & Wiltshire Mental Health Partnership NHS Trust • The Royal National Hospital for Rheumatic Diseases NHS Trust • All other NHS Trusts and Primary Care Trusts in the locality • The Bath Clinic • Dorothy House • Clouds House • HM Prison Erlestoke • Reach Out • Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 41 of 48 Appendix 7: Root Cause Analysis Following Blood or Body Fluid Exposure Root Cause Analysis (RCA) provides a framework for reviewing staff safety incidents [and claims and complaints]. Investigations can identify what, how, and why staff safety incidents have happened. Analysis can then be used to identify areas for change, develop recommendations and look for new solutions. Contributing Factors to a blood or body fluid exposure If YES - what contributed to this factor being an issue? YES NO Is this a root cause of the event? If YES, is an action plan indicated? YES YES NO 1. Issues related to patient assessment? 2. Issues related to staff training or staff competency? 3. Equipment / device? 4. Work environment? 5. Lack of or misinterpretation of information? 6. Communication? 7. Appropriate rules/policies/ procedures or lack thereof? 8. Worker issues 9. Supervisory issues Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 42 of 48 NO Sample Trigger Questions for Performing a Root Cause Analysis of a Blood or Body Fluid Exposure 1. Issues related to patient assessment • • • Was the patient agitated before the procedure? Was the patient cooperative before the procedure? Did the patient contribute in any way toward the event? 2. Issues related to staff training or staff competency • • 5. Was a lack of or misinterpretation of information contribute to this event? • Did the healthcare worker misinterpret any information about the procedure that could have contributed to the event? 6. Communication • Were there any communication barriers that contributed to this event [e.g., language] • Was communication in any way a contributing factor in this event? 7. Appropriate policies/procedures Did the healthcare worker receive training on injury prevention technique for the procedure performed? Are there training or competency factors • that contributed to this event? Approximately how many procedures of this type has the healthcare worker • performed in the last month/week? Are there existing policies or procedures that describe how this event should be • prevented? Were the appropriate policies or procedures followed? 3. Issues related to the device • If they were not followed, why not? • Did the type of device used contribute in 8. Worker issues any way to this event? • Did being right or left handed influence • Was a “safety” device used? If not, is the risk? it likely that a safety device could have • On the day of the exposure, how long prevented this event? had the worker been working before the 4. Work environment exposure occurred? At the time of the exposure, could • Did the location, fullness or lack of a factors such as worker fatigue, hunger, sharps container contribute to this illness, etc. have contributed? event? • Did the organisation of the work 9. Employer issues environment [e.g., placement of supplies, position of patient] influence • Did lack of supervision contribute to this the risk of injury? event? • Was there sufficient lighting? • Was crowding a factor? • Was there a sense of urgency to complete the procedure? Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 43 of 48 Action Plan - Risk Reduction Strategies Risk Reduction Strategies Action item #1 Measure[s] of Effectiveness Responsible Person[s] Action item #2 Action item #3 Action item #4 Action item #5 Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 44 of 48 Appendix 8: Risk categories for Viral Haemorrhagic Fevers Minimum risk This category includes febrile patients who have: • Not been in known endemic areas before the onset of illness; or • Been in endemic areas, (or in contact with a known or suspected source of a VHF), but in whom the onset of illness was definitely more than 21 days after their last contact with any potential source of infection. Moderate risk This category includes febrile patients who have: • Been in an endemic area during the 21 days before the onset of illness, but who have none of the additional risk factors which would place him or her in the high risk category; or • Not been in a known endemic area but who may have been in adjacent areas or countries during the 21 days before the onset of illness, and who have evidence of severe illness with organ failure and/or haemorrhage which could be due to a VHF and for which no alternative diagnosis is currently evident. High risk • This category includes febrile patients who: • Have been in an endemic area during the three weeks before illness and have lived in a house or stayed in a house for more than 4 hours where there were ill, feverish persons known or strongly suspected to have a VHF; or • took part in nursing or caring for ill, feverish patients known or strongly suspected to have a VHF, or had contact with the body fluids, tissue or the dead body of such a patient; or • Are a laboratory, health or other worker who has, or has been likely to have come into contact with the body fluids, tissues or the body of a human or animal known or strongly suspected to have a VHF; or • Were previously categorised as `moderate' risk, but who have developed organ failure and/or haemorrhage. • Have not been in an endemic area but during the three weeks before illness they • cared for a patient or animal known or strongly suspected to have a VHF or came into contact with the body fluids, tissues or dead body of such a patient or animal; or • Handled clinical specimens, tissues or laboratory cultures known or strongly suspected to contain the agent of a VHF. Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 45 of 48 Appendix 9: Rural African** Risk Assessment – Triage Form Modified from the Hospital for Tropical Diseases, London Name: Hospital No.: Date: 1. Has the patient been to an endemic country for VHF in the last month? Access the website for up to date information (http://www.hpa.org.uk/infections/topics_az/VHF/menu.htm) Endemic countries include: Guinea (-Conakry), Sierra Leone, Liberia, Cote d’Ivoire, Ghana, Togo, Benin, Nigeria, Mali, Burkina Faso, Niger, Central African Republic, Cameroon, Gabon, Democratic Republic of Congo, Sudan, Uganda, Chad, Congo, Equatorial Guinea, **the Crimean region of former USSR. YES � go to question 2 NO � risk is minimum, Proceed with triage as normal 2. Does the patient have an illness with fever of less than 21 days’ duration that started either while s/he was in the endemic country, or within 21 days of leaving an endemic country? YES � go to question 3 NO � if the illness started MORE than 21days after leaving endemic country, the risk is minimum, Proceed with triage as normal 3. Has the patient: • Travelled outside major cities?; Yes � No � • Had contact with sick people or been to health care facilities?: Yes � No � • Been in contact with rats or their excreta?: Yes � No � • Been in direct contact with wild animals; Yes � No � If the answer to any part of question 3 is YES, or there is another reason to suspect VHF, then DO NOT take any specimens from the patient, and discuss with the on-call Microbiologist. This does NOT necessarily mean that the patient is at risk of VHF, simply that further assessment is required. Malaria exclusion is vital in all cases however before blood is taken this must be discussed with the on-call Microbiologist and the on-call Haematologist. If the answer to all parts of question 3 is No, then document ‘minimal risk of VHF’ and continue with triage as normal. Action Discussed with Microbiology?: Yes � No If yes, level of seniority: SHO � SpR Consultant Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 46 of 48 Equality Impact Assessment Tool Initial Screening 1. Policy, service, strategy, procedure or function: Protection against Blood Borne Virus Infections and Management of Sharps and Contamination Incidents Lead (e.g. Director, Manager, Clinician): Colin Payton. 2. Person responsible for the assessment: Name: Colin Payton Job Title: Occupational Health consultant 3. Is this a new or existing policy, service strategy, procedure or function? New Existing 4. Who is the policy/service strategy, procedure or function aimed at? Patients Any other Carers Staff Please specify: Visitors 5. Are any of the following groups adversely affected by the policy? If yes is this high, medium or low impact (see attached notes): Group Disabled people: No Race, ethnicity & nationality No Male/Female/transgender: Affected? Yes High Impact Medium Low Yes High Medium Low No Yes High Medium Low Age, young or older people: No Yes High Medium Low Sexual orientation: No Yes High Medium Low Religion, belief and faith: No Yes High Medium Low If the answer is yes to any of these proceed to full assessment. This applies whether the impact assessment is high, medium or low. If the answer is no to all categories, the assessment is now complete 6. Does the policy, service strategy, procedure or function include measures which promote equality? No Yes 7. If yes, what are these measures? Health and safety arrangements apply equally to all staff including temporary workers, students and visitors exposed to medical sharps in the work place Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Ref.: 614 Status: Approved Page 47 of 48 Ratification Checklist Dear Chairman Please would you review this document at your next meeting and agree final approval and organisational ratification. Title of meeting: Health and Safety Committee Date of meeting: 31/01/2012 Title and Reference of document: Protection against Blood Borne Virus Infections and Management of Sharps and Contamination Incidents Name of author: Colin Payton / Stephen Roberts Are there any elements of this policy which present operational issues that require further discussion? If yes, please provide a contact name for the author. Does the document include a training plan? Is the policy referenced? Are up to date National Guidelines included? If you are the appropriate forum, have the necessary resources been agreed to implement this document? Is there a plan for policy implementation? Does your meeting recommend further consultation with groups or staff other than listed at the front of the policy? What are the cost implications of implementing this policy? Yes No N/A Yes No N/A Yes Yes Yes No No No N/A N/A N/A Yes No N/A Yes No N/A Yes NO N/A Yes No N/A Equipment £0 Yes No N/A Staffing [additional] £0 Yes No N/A Training £0 Yes No N/A Other £0 Yes No N/A Document endorsed without further comment? Further amendments to document suggested? Managers guide to investigating a medical sharps incident Yes No Yes No Name of Chair: Howard Jones Signature: Signed following the meeting Document name: Protection against blood borne virus infections and management of sharps and contamination incidents Issue date: 13 February 2012 Author: Colin Payton and Stephen Roberts . Date: 01.02.12 Ref.: 614 Status: Approved Page 48 of 48